Manufacturer record
Macmillon Pharmaceuticals Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Macmillon Pharmaceuticals Pvt Ltd (Punjab) were declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L09-2501, METHOTREXATE TABLETS IP 7.5 MG (exp Jan 2027). Govt Analyst Punjab (state lab) found it not of standard quality: Description. Listed in the July 2026 alert.
Records by type
2 records linked to Macmillon Pharmaceuticals Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| METHOTREXATE TABLETS IP 7.5 MG | Batch L09-2501Mfg Feb 2025 · Exp Jan 2027 | DescriptionDescription | Govt Analyst PunjabState lab | Jul 2026 |
| METHOTREXATE TABLETS IP 7.5 MG | Batch L09-2402Mfg Dec 2024 · Exp Nov 2026 | DescriptionDescription | Govt Analyst PunjabState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.